Joint Formulary & PAD

Tolcapone - Parkinson's disease

You are here : Home > Formulary Search > Tolcapone - Parkinson's disease

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Amber
Formulations :
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
SPC
Restrictions / Comments :

Documentation

Shared Care
Tolcapone for the treatment of Parkinson's Disease - Shared Care - January 2026

PAD Profile

ChemicalSubstance :
Tolcapone
Indication :
Parkinson's disease
Group Name :
Keywords :
PD, shared care
Brand Names Include :
Tasmar
Important Information :

For tolcapone specific shared care click on drug name.

Principles for shared care found here: https://surrey.res.services/PAD/Profile/NonClinicalProfile/9136

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1

Committee Recommendations (2)

04 Feb 26 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Care System Area Prescribing Committee have agreed the review of the AMBER shared care document for tolcapone use in the treatment of Parkinson’s Disease

28 Aug 13 - Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

It was noted that this drug is now rarely used but it was agreed that it would be useful to have a shared care document agreed for the occasional patient in whom it would be appropriate to use. The PCN supported the shared care document.

Other Indications

Below are listed other indications that Tolcapone is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Parkinson's disease.